These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8688493)

  • 21. Lack of association of severe preeclampsia with maternal and fetal mutant alleles for tumor necrosis factor alpha and lymphotoxin alpha genes and plasma tumor necrosis factor alpha levels.
    Livingston JC; Park V; Barton JR; Elfering S; Haddad B; Mabie WC; Quasney M; Sibai BM
    Am J Obstet Gynecol; 2001 May; 184(6):1273-7. PubMed ID: 11349201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cytokine microenvironment of human colon carcinoma. Lymphocyte expression of tumor necrosis factor-alpha and interleukin-4 predicts improved survival.
    Barth RJ; Camp BJ; Martuscello TA; Dain BJ; Memoli VA
    Cancer; 1996 Sep; 78(6):1168-78. PubMed ID: 8826937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor necrosis factor family ligand-receptor binding.
    Zhang G
    Curr Opin Struct Biol; 2004 Apr; 14(2):154-60. PubMed ID: 15093829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteoprotegerin secretion from prostate cancer is stimulated by cytokines, in vitro.
    Penno H; Silfverswärd CJ; Frost A; Brändström H; Nilsson O; Ljunggren O
    Biochem Biophys Res Commun; 2002 Apr; 293(1):451-5. PubMed ID: 12054622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ligands and receptors of the lymphotoxin system.
    Ware CF; VanArsdale TL; Crowe PD; Browning JL
    Curr Top Microbiol Immunol; 1995; 198():175-218. PubMed ID: 7774281
    [No Abstract]   [Full Text] [Related]  

  • 26. Association between polymorphisms in tumor necrosis factor (TNF) and TNF receptor genes and circulating TNF, soluble TNF receptor levels, and bone mineral density in postmenopausal Korean women.
    Kim H; Chun S; Ku SY; Suh CS; Choi YM; Kim JG
    Menopause; 2009; 16(5):1014-20. PubMed ID: 19369902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Biosynthesis of alpha2-interferon and tumor necrosis factor at different stages of culturing].
    Andreeva IS; Lebedev LR; Sinichkina SA; Puchkova LI; Pustoshilova NM
    Mol Gen Mikrobiol Virusol; 1996; (3):23-6. PubMed ID: 8999314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythropoietin-dependent autocrine secretion of tumor necrosis factor-alpha in hematopoietic cells modulates proliferation via MAP kinase--ERK-1/2 and does not require tyrosine docking sites in the EPO receptor.
    Chen J; Jacobs-Helber SM; Barber DL; Sawyer ST
    Exp Cell Res; 2004 Aug; 298(1):155-66. PubMed ID: 15242770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of lymphotoxin in experimental models of infectious diseases: potential benefits and risks of a therapeutic inhibition of the lymphotoxin-beta receptor pathway.
    Spahn TW; Eugster HP; Fontana A; Domschke W; Kucharzik T
    Infect Immun; 2005 Nov; 73(11):7077-88. PubMed ID: 16239501
    [No Abstract]   [Full Text] [Related]  

  • 30. Lymph nodal prion replication and neuroinvasion in mice devoid of follicular dendritic cells.
    Prinz M; Montrasio F; Klein MA; Schwarz P; Priller J; Odermatt B; Pfeffer K; Aguzzi A
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):919-24. PubMed ID: 11792852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor necrosis factor alpha-induced activation of c-jun N-terminal kinase is mediated by TRAF2.
    Reinhard C; Shamoon B; Shyamala V; Williams LT
    EMBO J; 1997 Mar; 16(5):1080-92. PubMed ID: 9118946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Death receptor-induced apoptotic and necrotic cell death: differential role of caspases and mitochondria.
    Denecker G; Vercammen D; Steemans M; Vanden Berghe T; Brouckaert G; Van Loo G; Zhivotovsky B; Fiers W; Grooten J; Declercq W; Vandenabeele P
    Cell Death Differ; 2001 Aug; 8(8):829-40. PubMed ID: 11526436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response to the letter to the editor.
    Etemadi N; Silke J; Nachbur U
    Immunol Cell Biol; 2014 Apr; 92(4):301-2. PubMed ID: 24751613
    [No Abstract]   [Full Text] [Related]  

  • 34. Progranulin inhibition of TNFα.
    Uddin SM; Mundra JJ; Jian J; Tian Q; Gonzalez-Gugel E; Richbourgh B; Liu CJ
    Immunol Cell Biol; 2014 Apr; 92(4):299-300. PubMed ID: 24518982
    [No Abstract]   [Full Text] [Related]  

  • 35. Porcine TNF: a review.
    Pauli U
    Vet Immunol Immunopathol; 1995 Aug; 47(3-4):187-201. PubMed ID: 8571540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tumor necrosis factor].
    Aderka D; Levo Y
    Harefuah; 1987 Apr; 112(7):357-9. PubMed ID: 3497850
    [No Abstract]   [Full Text] [Related]  

  • 37. [Current developments in the field of sepsis: tumor necrosis factor (cachectin)].
    van Deventer SJ; Debets JM; Büller HR; ten Cate JW; van der Linden CJ; Buurman WA
    Ned Tijdschr Geneeskd; 1989 Jan; 133(1):17-9. PubMed ID: 2644550
    [No Abstract]   [Full Text] [Related]  

  • 38. Acute effects of tumor necrosis factor-alpha or lymphotoxin on oxygenation and bioenergetic status in experimental tumors.
    Engel T; Vaupel P
    Adv Exp Med Biol; 1994; 345():501-8. PubMed ID: 8079750
    [No Abstract]   [Full Text] [Related]  

  • 39. Why is too little TNF bad?
    Bendtzen K
    Cytokine; 1991 Nov; 3(6):636-7. PubMed ID: 1790308
    [No Abstract]   [Full Text] [Related]  

  • 40. The tumor necrosis factors: cachectin and lymphotoxin.
    Beutler B
    Hosp Pract (Off Ed); 1990 Feb; 25(2):45-56. PubMed ID: 2105975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.